Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ACAT-inhibitory urea derivatives claimed by Mitsubishi for lipid disorders

Jan. 7, 1999

Study in ovariectomized monkeys supports potential of zoledronate for osteoporosis

Jan. 5, 1999

Lilly obtains license for technology expected to broaden indications for Humatrope

Jan. 5, 1999

JTT-501 improves insulin resistance in two rodent models

Jan. 5, 1999

ACE inhibitor trandolapril improves peripheral neuropathy in normotensive diabetic patients

Jan. 4, 1999

MCC-555 improves metabolic status, insulin sensitivity in diabetic and obese rat models

Jan. 4, 1999

Physician recommendations for Viagra use issued

Jan. 4, 1999

Prometrium cleared for U.S. marketing for HRT

Jan. 4, 1999

Novel enzyme inhibitors from microbial source claimed by HMR as antidiabetics

Dec. 29, 1998

Amgen's rights to NESP affirmed by arbitrator panel

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...